chr6-169217827-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_003247.5(THBS2):āc.3514A>Gā(p.Ile1172Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000783 in 1,571,472 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_003247.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
THBS2 | NM_003247.5 | c.3514A>G | p.Ile1172Val | missense_variant, splice_region_variant | 22/22 | ENST00000617924.6 | |
THBS2-AS1 | NR_134621.1 | n.681+3340T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
THBS2 | ENST00000617924.6 | c.3514A>G | p.Ile1172Val | missense_variant, splice_region_variant | 22/22 | 1 | NM_003247.5 | P4 | |
THBS2-AS1 | ENST00000660724.1 | n.639+3340T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 30AN: 111616Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000577 AC: 13AN: 225440Hom.: 0 AF XY: 0.0000406 AC XY: 5AN XY: 123248
GnomAD4 exome AF: 0.0000630 AC: 92AN: 1459780Hom.: 1 Cov.: 31 AF XY: 0.0000606 AC XY: 44AN XY: 726098
GnomAD4 genome AF: 0.000278 AC: 31AN: 111692Hom.: 0 Cov.: 34 AF XY: 0.000316 AC XY: 17AN XY: 53846
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at